United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 217,868 | 174,679 | 90,281 | 16,390 | 105,916 |
| Depreciation Amortization | 44,368 | 32,690 | 22,103 | 11,445 | 37,333 |
| Income taxes - deferred | 81,432 | 65,384 | 46,159 | 10,436 | 41,923 |
| Accounts receivable | -16,158 | -14,651 | -9,486 | 7,928 | -23,452 |
| Accounts payable and accrued liabilities | 20,251 | 1,040 | 891 | -6,150 | -2,734 |
| Other Working Capital | -111,254 | -76,261 | -54,974 | -24,567 | -72,411 |
| Other Operating Activity | 13,688 | 15,685 | 22,914 | 37,869 | 124,957 |
| Operating Cash Flow | $250,195 | $198,566 | $117,888 | $53,351 | $211,532 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -81,808 | -97,237 | -60,664 | -173,249 | -204,497 |
| PPE Investments | -35,978 | -36,725 | -18,883 | -6,336 | -18,640 |
| Sale Of Investment | N/A | N/A | N/A | 144,250 | N/A |
| Purchase Sale Intangibles | -3,547 | -3,547 | N/A | N/A | N/A |
| Other Investing Activity | -3,547 | -3,547 | 0 | 0 | 13,901 |
| Investing Cash Flow | $-121,333 | $-137,509 | $-79,547 | $-35,335 | $-209,236 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 250,000 | N/A | N/A | N/A | 70,000 |
| Debt Repayment | -284,289 | N/A | N/A | N/A | -31,442 |
| Common Stock Issued | 24,398 | 23,948 | 23,724 | 13,976 | 85,427 |
| Common Stock Repurchased | -212,000 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 3,812 | 6,486 | 6,289 | 3,976 | 22,771 |
| Financing Cash Flow | $-218,079 | $30,434 | $30,013 | $17,952 | $146,756 |
| Exchange Rate Effect | -269 | 331 | 605 | 833 | 2,758 |
| Beginning Cash Position | 252,162 | 252,162 | 252,162 | 252,162 | 100,352 |
| End Cash Position | 162,676 | 343,984 | 321,121 | 288,963 | 252,162 |
| Net Cash Flow | $-89,486 | $91,822 | $68,959 | $36,801 | $151,810 |
| Free Cash Flow | |||||
| Operating Cash Flow | 250,195 | 198,566 | 117,888 | 53,351 | 211,532 |
| Capital Expenditure | -35,978 | -36,725 | -18,883 | -6,336 | -18,640 |
| Free Cash Flow | 214,217 | 161,841 | 99,005 | 47,015 | 192,892 |